venlafaxine hydrochloride has been researched along with Chronic Insomnia in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (18.18) | 18.2507 |
| 2000's | 8 (36.36) | 29.6817 |
| 2010's | 8 (36.36) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Han, YS; Jiang, HX; Li, CY; Li, ZR; Liu, DG; Wang, YH; Xie, S; Zou, MS | 1 |
| Bell, C; Hobbs, G; Signorelli, J | 1 |
| Anderson, GL; Carpenter, JS; Ensrud, KE; Freeman, EW; Guthrie, KA; Joffe, H; LaCroix, AZ; Larson, JC; Manson, JE; McCurry, SM; Morin, CM; Newton, KM; Otte, J; Reed, SD | 1 |
| Caan, B; Carpenter, JS; Ensrud, KE; Freeman, EW; Guthrie, KA; Hohensee, C; Joffe, H; LaCroix, AZ; Landis, CA; Manson, J; Newton, KM; Otte, J; Reed, SD; Shifren, JL; Sternfeld, B; Woods, NF | 1 |
| Luther, JF; Rush, AJ; Sung, SC; Trivedi, MH; Wisniewski, SR | 1 |
| Ehler, E; Meleková, A | 1 |
| Aizenstein, H; Anderson, SJ; Butters, MA; Dew, MA; Lenze, EJ; Lotrich, FE; Mulsant, BH; Reynolds, CF; Smagula, SF | 1 |
| Asadi, M; Davari-Tanha, F; Hadizadeh, H; Shariat, M; Shirazi, M; Soleymani-Farsani, M | 1 |
| Baker, RA; Berman, RM; Carlson, BX; Eudicone, JM; Mankoski, R; Nelson, JC; Pikalov, A; Tran, QV | 1 |
| Baune, BT; Caliskan, S; Todder, D | 1 |
| Cooper-Kazaz, R | 1 |
| Borgeat, F; Hättenschwiler, J; Khazaal, Y; Mattia, M; Stankovic, M; Zullino, DF | 1 |
| Aït-Ameur, A; Bertschy, G; Ferrero, F; Muscionico, M; Osiek, C; Ragama-Pardos, E; Roth, L | 1 |
| Gelenberg, AJ; Liebowitz, MR; Munjack, D | 1 |
| Lange, CL | 1 |
| Case, K; Cramer-Bornemann, M; Hurwitz, TD; Kim, SW; Schenck, CH | 1 |
| Nelson, JC | 1 |
| Mitchell, S; Tracy, KA; Zajecka, J | 1 |
| Thase, ME | 2 |
| Jacob, C; Luckhaus, C | 1 |
| Culpepper, L | 1 |
5 review(s) available for venlafaxine hydrochloride and Chronic Insomnia
| Article | Year |
|---|---|
[Pharmacotherapy of generalized anxiety disorder: state of the art].
Topics: Adolescent; Adult; Age Factors; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Benzodiazepines; Child; Child, Preschool; Cyclohexanols; Double-Blind Method; Humans; Meta-Analysis as Topic; Paroxetine; Placebos; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Time Factors; Venlafaxine Hydrochloride | 2003 |
Safety and tolerability of the new antidepressants.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Headache; Humans; Mianserin; Mirtazapine; Nausea; Piperazines; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Triazoles; Venlafaxine Hydrochloride | 1997 |
Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.
Topics: 1-Naphthylamine; Adolescent; Adult; Child; Clinical Trials as Topic; Cyclohexanols; Dizziness; Female; Fluoxetine; Fluvoxamine; Headache; Humans; Infant; Infant, Newborn; Male; MEDLINE; Mental Disorders; Middle Aged; Nausea; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensation Disorders; Sertraline; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 1997 |
Antidepressant treatment of the depressed patient with insomnia.
Topics: Antidepressive Agents, Tricyclic; Comorbidity; Cyclohexanols; Depressive Disorder; Fluoxetine; Humans; Mianserin; Mirtazapine; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sleep; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 1999 |
Generalized anxiety disorder in primary care: emerging issues in management and treatment.
Topics: Adaptation, Psychological; Adolescent; Adult; Anxiety Disorders; Cognitive Behavioral Therapy; Comorbidity; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Physicians, Family; Prevalence; Primary Health Care; Recurrence; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; United States; Venlafaxine Hydrochloride | 2002 |
7 trial(s) available for venlafaxine hydrochloride and Chronic Insomnia
| Article | Year |
|---|---|
Effects of Pharmacologic and Nonpharmacologic Interventions on Insomnia Symptoms and Self-reported Sleep Quality in Women With Hot Flashes: A Pooled Analysis of Individual Participant Data From Four MsFLASH Trials.
Topics: Antidepressive Agents, Second-Generation; Citalopram; Cognitive Behavioral Therapy; Double-Blind Method; Estradiol; Exercise; Exercise Therapy; Fatty Acids, Omega-3; Female; Hot Flashes; Humans; Meditation; Menopause; Middle Aged; Outcome Assessment, Health Care; Placebos; Self Report; Sleep; Sleep Initiation and Maintenance Disorders; Venlafaxine Hydrochloride; Yoga | 2018 |
Effects of estradiol and venlafaxine on insomnia symptoms and sleep quality in women with hot flashes.
Topics: Cyclohexanols; Double-Blind Method; Estradiol; Estrogens; Female; Hot Flashes; Humans; Menopause; Middle Aged; Perimenopause; Sleep; Sleep Initiation and Maintenance Disorders; Venlafaxine Hydrochloride | 2015 |
Pre-treatment insomnia as a predictor of single and combination antidepressant outcomes: a CO-MED report.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety Disorders; Bupropion; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Outpatients; Predictive Value of Tests; Single-Blind Method; Sleep Initiation and Maintenance Disorders; Substance-Related Disorders; Surveys and Questionnaires; Treatment Outcome; United States; Venlafaxine Hydrochloride | 2015 |
Comparison of citalopram and venlafaxine's role in treating sleep disturbances in menopausal women, a randomized, double-blind, placebo-controlled trial.
Topics: Citalopram; Depression; Double-Blind Method; Female; Hot Flashes; Humans; Iran; Middle Aged; Postmenopause; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Severity of Illness Index; Sleep; Sleep Initiation and Maintenance Disorders; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride | 2016 |
Effects of aripiprazole adjunctive to standard antidepressant treatment on the core symptoms of depression: a post-hoc, pooled analysis of two large, placebo-controlled studies.
Topics: Adult; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Surveys and Questionnaires; Venlafaxine Hydrochloride | 2010 |
Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.
Topics: Adult; Cyclohexanols; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Nausea; Paroxetine; Phobic Disorders; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Efficacy and tolerability of once-daily venlafaxine extended release (XR) in outpatients with major depression. The Venlafaxine XR 209 Study Group.
Topics: Adult; Ambulatory Care; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Nausea; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Venlafaxine Hydrochloride | 1997 |
10 other study(ies) available for venlafaxine hydrochloride and Chronic Insomnia
| Article | Year |
|---|---|
Sleep deprivation leads to further impairment of hippocampal synaptic plasticity by suppressing melatonin secretion in the pineal gland of chronically unpredictable stress rats.
Topics: Animals; Depression; Hippocampus; Melatonin; Neuronal Plasticity; Pineal Gland; Rats; Sleep Deprivation; Sleep Initiation and Maintenance Disorders; Stress, Psychological; Venlafaxine Hydrochloride | 2022 |
Anxiety exacerbation in a patient with chronic myeloid leukemia receiving dasatinib and venlafaxine.
Topics: Aged; Anxiety; Dasatinib; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Protein Kinase Inhibitors; Quality of Life; Sleep Initiation and Maintenance Disorders; Venlafaxine Hydrochloride | 2023 |
Neuromyotonia with polyneuropathy, prominent psychoorganic syndrome, insomnia, and suicidal behavior without antibodies: a case report.
Topics: Adrenergic alpha-Antagonists; Aged; Antidepressive Agents, Second-Generation; Electromyography; Humans; Immunoglobulins, Intravenous; Isaacs Syndrome; Male; Mianserin; Mirtazapine; Polyneuropathies; Sleep Initiation and Maintenance Disorders; Suicide, Attempted; Venlafaxine Hydrochloride | 2015 |
Antidepressant Response Trajectories and Associated Clinical Prognostic Factors Among Older Adults.
Topics: Aged; Antidepressive Agents; Bayes Theorem; Depressive Disorder, Major; Disease Progression; Female; Guilt; Humans; Linear Models; Male; Middle Aged; Prognosis; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Venlafaxine Hydrochloride | 2015 |
Longitudinal changes of day-time and night-time gross motor activity in clinical responders and non-responders of major depression.
Topics: Actigraphy; Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Circadian Rhythm; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Longitudinal Studies; Male; Middle Aged; Motor Activity; Personality Inventory; Prognosis; Prospective Studies; Quetiapine Fumarate; Signal Processing, Computer-Assisted; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Treatment of night eating syndrome with topiramate: dawn of a new day.
Topics: Anticonvulsants; Antidepressive Agents, Second-Generation; Circadian Rhythm; Cyclohexanols; Drug Therapy, Combination; Feeding and Eating Disorders; Feeding Behavior; Female; Fructose; Humans; Middle Aged; Sleep Initiation and Maintenance Disorders; Topiramate; Venlafaxine Hydrochloride | 2012 |
Trazodone addition for insomnia in venlafaxine-treated, depressed inpatients: a semi-naturalistic study.
Topics: Adult; Chi-Square Distribution; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Prospective Studies; Sleep Initiation and Maintenance Disorders; Statistics, Nonparametric; Trazodone; Venlafaxine Hydrochloride | 2005 |
Medication-associated somnambulism.
Topics: Adolescent; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Hypnotics and Sedatives; Pyridines; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Somnambulism; Venlafaxine Hydrochloride; Zolpidem | 2005 |
A case of extreme paradoxical insomnia responding selectively to electroconvulsive therapy.
Topics: Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Diagnosis, Differential; Dibenzothiazepines; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Humans; Middle Aged; Quetiapine Fumarate; Sick Role; Sleep Initiation and Maintenance Disorders; Suicide; Suicide Prevention; Venlafaxine Hydrochloride | 2008 |
Venlafaxine withdrawal syndrome not prevented by maprotiline, but resolved by sertraline.
Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Female; Humans; Maprotiline; Nausea; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2001 |